Rare Biomarkers: Transforming Non-Small Cell Lung Cancer Treatment with New Therapies | #capmatinib # tepmetko cost # tepmetko price # capmatinib approval # merck biomarker non-small cell lung cancer # met inhibitors for lung cancer market # capmatinib novartis